--- Connecting LPs & GPs worldwide
--- Connecting LPs & GPs worldwide
PureTech Ventures, a firm focused on creation and early stage investment in therapeutics, medical devices, diagnostics, and research technologies, has added John LaMattina as a senior partner. LaMattina was previously president of Pfizer Global Research & Development and executive vice president of pharmaceuticals giant Pfizer, Inc.
In order to view premium content you need to be a Premium Subscriber. You can subscribe now to access premium online content.
Become a Premium SubscriberIf you are already a AltAssets subscriber please log in below.
